HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration
Authors
Keywords
Mouse models, Enzyme-linked immunoassays, Cytoplasmic inclusions, Huntington disease, Mice, Neostriatum, Immunohistochemistry techniques, Immunoprecipitation
Journal
PLOS BIOLOGY
Volume 11, Issue 11, Pages e1001717
Publisher
Public Library of Science (PLoS)
Online
2013-11-27
DOI
10.1371/journal.pbio.1001717
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
- (2013) K. Sathasivam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of protein aggregation by chaperone modification of high molecular weight complexes
- (2012) John Labbadia et al. BRAIN
- Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression
- (2012) Dongbo Yu et al. CELL
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- Genetic Knock-Down of Hdac3 Does Not Modify Disease-Related Phenotypes in a Mouse Model of Huntington's Disease
- (2012) Lara Moumné et al. PLoS One
- SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo
- (2012) Anna Bobrowska et al. PLoS One
- Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis
- (2011) Maria M. Mihaylova et al. CELL
- Oligonucleotide therapeutic approaches for Huntington disease
- (2011) Dinah W.Y. Sah et al. JOURNAL OF CLINICAL INVESTIGATION
- Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease
- (2011) John Labbadia et al. JOURNAL OF CLINICAL INVESTIGATION
- Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease
- (2011) Anna Bobrowska et al. PLoS One
- SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease
- (2011) Michal Mielcarek et al. PLoS One
- Essential Role of Coiled Coils for Aggregation and Activity of Q/N-Rich Prions and PolyQ Proteins
- (2010) Ferdinando Fiumara et al. CELL
- Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases
- (2010) Viviana Moresi et al. CELL
- Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease
- (2010) Christian Landles et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Single-step detection of mutant huntingtin in animal and human tissues: A bioassay for Huntington’s disease
- (2009) Andreas Weiss et al. ANALYTICAL BIOCHEMISTRY
- Huntington's disease: The current state of research with peripheral tissues
- (2009) Jenny Sassone et al. EXPERIMENTAL NEUROLOGY
- Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease
- (2009) Kirupa Sathasivam et al. HUMAN MOLECULAR GENETICS
- Histone deacetylase inhibitors: Potential in cancer therapy
- (2009) P.A. Marks et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Regional and subcellular distribution of HDAC4 in mouse brain
- (2009) Michael J. Darcy et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease
- (2009) Mark Kilgore et al. NEUROPSYCHOPHARMACOLOGY
- Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease
- (2009) Caroline L. Benn et al. PLoS One
- HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2
- (2008) Annamaria Scognamiglio et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Structural and Functional Analysis of the Human HDAC4 Catalytic Domain Reveals a Regulatory Structural Zinc-binding Domain
- (2008) Matthew J. Bottomley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease
- (2008) Caroline L Benn et al. Molecular Neurodegeneration
- Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
- (2008) Aleksey G. Kazantsev et al. NATURE REVIEWS DRUG DISCOVERY
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation